Analyst stock forecast
Prime Medicine Forecast: $7.11 Analyst Target
Direct answer
Prime Medicine's average price target is $7.11.
The target implies +105% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +22.5%, the high target implies +217%, and the range spans 194.5% of the current price.
Forecast evidence checked October 17, 2026.
Get free Prime Medicine email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.47
- Average price target
- $7.11
- High price target
- $11.00
- Low price target
- $4.25
- Low target gap
- +22.5%
- Target upside
- +105%
- High target gap
- +217%
- Target range width
- 194.5%
- Consensus rating
- Strong Buy
- Analysts
- 11
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is Prime Medicine's average price target?
Prime Medicine's verified average price target is $7.11. The target range is $4.25 to $11.00.
How far are Prime Medicine's low and high targets from the recorded price?
The low target implies +22.5%, while the high target implies +217%.
How many analysts are included in Prime Medicine's consensus?
The verified consensus includes 11 analysts.
How is Prime Medicine's target upside or downside calculated?
The average target of $7.11 is divided by the recorded price of $3.47, then one is subtracted to produce +105%. This does not guarantee a future return.
When was Prime Medicine's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.